BackNKGen Biotech Overview

NKGen Biotech Receivables

Latest receivables for NKGN: $0.

Get informed when a big investor buys or sells

+ Follow
Receivables
$0.00
↓ 100.00% YoYΔ $-26000.00 vs prior year quarter

Peer average

Loading

NKGen Biotech Receivables History

Loading

NKGen Biotech vs. peers: Receivables Comparison

Loading

NKGen Biotech Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

NKGen Biotech (NKGN) FAQ

NKGen Biotech (NKGN) currently reports a receivables of $0 as of March 2025. That compares with $26K in the prior-year period — down 100.0% year over year. Use the charts on this page to explore NKGen Biotech's receivables history and peer comparisons.

NKGen Biotech's receivables decreased from $26K to $0 — a 100.0% year-over-year decrease (period ending March 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

NKGen Biotech reported $0 in receivables as of March 2025. That compares with $26K in the prior-year period — down 100.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for NKGen Biotech, and consider following NKGN for alerts when major investors trade the stock.